| LILRB4 suppresses immunity in solid tumors and is a potential target for immunotherapy N Sharma, OT Atolagbe, Z Ge, JP Allison Journal of Experimental Medicine 218 (7), 2021 | 95 | 2021 |
| TLR1/2 ligand enhances antitumor efficacy of CTLA-4 blockade by increasing intratumoral Treg depletion N Sharma, J Vacher, JP Allison Proceedings of the National Academy of Sciences 116 (21), 10453-10462, 2019 | 75 | 2019 |
| Sphingosine-1-phosphate suppresses TLR-induced CXCL8 secretion from human T cells N Sharma, AS Akhade, A Qadri Journal of leukocyte biology 93 (4), 521-528, 2013 | 67 | 2013 |
| CD8 T cells enter the splenic T cell zones independently of CCR7, but the subsequent expansion and trafficking patterns of effector T cells after infection are dysregulated in … N Sharma, AP Benechet, L Lefrançois, KM Khanna The Journal of Immunology 195 (11), 5227-5236, 2015 | 48 | 2015 |
| Src kinases central to T-cell receptor signaling regulate TLR-activated innate immune responses from human T cells N Sharma, AS Akhade, A Qadri Innate Immunity 22 (3), 238-244, 2016 | 19 | 2016 |
| Neoantigen-specific cytotoxic Tr1 CD4 T cells suppress cancer immunotherapy H Sultan, Y Takeuchi, JP Ward, N Sharma, TT Liu, V Sukhov, M Firulyova, ... Nature 632 (8023), 182-191, 2024 | 14 | 2024 |
| Serum-borne lipids amplify TLR-activated inflammatory responses N Sharma, AS Akhade, S Ismaeel, A Qadri Journal of Leucocyte Biology 109 (4), 821-831, 2021 | 11 | 2021 |
| ICOS costimulation in combination with CTLA-4 blockade remodels tumor-associated macrophages toward an antitumor phenotype N Sharma, X Fan, OT Atolagbe, Z Ge, KN Dao, P Sharma, JP Allison Journal of Experimental Medicine 221 (4), 2024 | 8 | 2024 |
| LILRB4-binding antibody and methods of use thereof N Sharma, JP Allison US Patent 12,180,277, 2024 | | 2024 |
| 1006 High doses of MHC-II neoantigens in peptide cancer vaccines induce tumor-specific inhibitory cytolytic CD4+ T cells H Sultan, Y Takeuchi, J Ward, M Firulyova, TT Liu, N Sharma, Y Song, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| TLR1/2 ligand promotes Fc gamma RIV mediated depletion of tumor-infiltrating treg by anti-CTLA-4 antibody and its antitumor efficacy N Sharma, JP Allison CANCER IMMUNOLOGY RESEARCH 6 (9), 2018 | | 2018 |
| Fc gamma receptor IV mediated depletionof tumor infiltrating regulatory T cells by anti-CTLA4 antibody is promoted byTLR1/2 agonist and hence its efficacy in anti-tumor … N Sharma, JP Allison CANCER IMMUNOLOGY RESEARCH 4 (11), 2016 | | 2016 |
| Abstract B143: Fc gamma receptor IV mediated depletionof tumor infiltrating regulatory T cells by anti-CTLA4 antibody is promoted byTLR1/2 agonist and hence its efficacy in … N Sharma, JP Allison Cancer Immunology Research 4 (11_Supplement), B143-B143, 2016 | | 2016 |
| Differential requirement for CCR7 expression in primary and secondary CD8 T cell responses to infection (69.9) N Sharma, L Lefrançois The Journal of Immunology 188 (1_Supplement), 69.9-69.9, 2012 | | 2012 |
| Immunological techniques and their applications KS Srikanth, N Sharma, R Garg, A Qadri | | 2008 |
